SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 25, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $5.5M total
Actionable Insight • Neutral

The insider sales are routine liquidity events tied to option exercises and do not signal a bearish view given the trivial proportion of market cap. Monitor for any material news (pipeline data, regulatory updates) that could explain the timing, but the cluster itself is not actionable.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$215.44
T+0 close · Aug 25, 2026 · via day close
Latest settled
−7.23%
T+20 · $199.86 · next T+60 in 2d
Vs SPY
−7.38%
α at T+20
Latest observation
−7.54%
T+55 · FF3 residual α
  1. T+0 · Aug 26 $215.44entry
  2. T+1 · 3mo ago +2.65%α +2.00% · $221.15
  3. T+5 · 3mo ago −2.88%α −2.76% · $209.23
  4. T+20 · 8w ago −7.23%α −7.38% · $199.86
  5. T+57 · todayOpen
  6. T+60 · in 2d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Revolution Medicines, General Counsel Jeff Cislini and Director Mark Goldsmith, sold a combined ~$22.5M in open-market sales on August 21, 2026, following option exercises. The total open-market sales of ~$22.5M represent approximately 0.05% of RVMD's $45.3B market cap, which is below the 0.1% threshold for materiality. While the cluster timing is notable (same-day sales by both insiders), the dollar amount relative to market cap is trivial, and the sales are clearly tied to option exercises (liquidity-driven, not informational).

Key Financial Metrics

Direction
selling
Total Value
$22.5M
Insiders
2

Key Facts

  • Two insiders sold shares on August 21, 2026: General Counsel Jeff Cislini and Director Mark Goldsmith
  • Total open-market sales: ~$22.5M (Cislini: ~$11.9M, Goldsmith: ~$10.5M)
  • All sales followed option exercises, Cislini exercised options at $0 and $18.56-$21.61 strike, Goldsmith exercised options at $0 strike
  • Total sales represent ~0.05% of RVMD's $45.3B market cap, below the 0.1% materiality threshold
  • No insider buying in the cluster, net direction is selling
  • RVMD has 93% analyst bullish consensus (26 Buy/10 Strong Buy out of 28 analysts)

Financial Impact

Total open-market sales of ~$22.5M represent ~0.05% of market cap, trivial relative to company size

insider ownershipdilution

Risk Factors

  • Insider sales could accelerate if the stock continues its strong run (up ~12%+ on average per prior reports)
  • Option exercises increase share count modestly, though the dilution is immaterial at this scale

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1787728254135

US Market Status

Market Closed · Opens Wed (10h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 26, 2026